Approximating the Proportion of Individuals With Kidney Failure Who Die Without Kidney Replacement Therapy in Ontario, Canada.

IF 1.6 Q3 UROLOGY & NEPHROLOGY
Canadian Journal of Kidney Health and Disease Pub Date : 2025-03-14 eCollection Date: 2025-01-01 DOI:10.1177/20543581251323961
Andrea C Cowan, Nivethika Jeyakumar, Amit X Garg, Stephanie Dixon, Bin Luo, Peter G Blake
{"title":"Approximating the Proportion of Individuals With Kidney Failure Who Die Without Kidney Replacement Therapy in Ontario, Canada.","authors":"Andrea C Cowan, Nivethika Jeyakumar, Amit X Garg, Stephanie Dixon, Bin Luo, Peter G Blake","doi":"10.1177/20543581251323961","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Quantifying the number and proportion of people with kidney failure (KF) who receive conservative kidney management is vital for health care system benchmarking and planning. It is not easy to ascertain this value precisely at the population level, but we can approximate it using information from different data sources to estimate the proportion of patients with advanced kidney disease who die without receiving dialysis or a transplant and should receive conservative kidney management.</p><p><strong>Objective: </strong>To approximate the proportion of people with KF in Ontario, Canada, who die without receiving kidney replacement therapy.</p><p><strong>Design: </strong>A review of unpublished provincial renal agency reports of 3 retrospective population-based cohorts combined with clinical interpretation.</p><p><strong>Patients: </strong>The 3 cohorts of people were: 1. those who died between January 1, 2013 and December 31, 2017, with an estimated glomerular filtration rate (eGFR) <10 mL/min/1.73 m<sup>2</sup> and no evidence of receiving kidney replacement therapy; 2. those who initiated outpatient maintenance dialysis or received a preemptive transplant in the same period; and 3. those with a sustained low eGFR ≤ 10 mL/min/1.73 m<sup>2</sup> between April 1, 2015 and March 31, 2018, and were followed for 1 year to determine if they started dialysis. In this last cohort, patients whose kidney function improved (evidence of an eGFR > 10 mL/min/1.73 m<sup>2</sup>) or who received a transplant during follow-up were excluded from the analysis.</p><p><strong>Measurements and methods: </strong>The 3 cohorts were derived at ICES and used linked health care databases for the province of Ontario, Canada. In 2016, Ontario had a population of about 14 million people. Two nephrologists reviewed the data to provide the clinical approximation.</p><p><strong>Results: </strong>There were 1891 individuals with KF who died without kidney replacement (the no KRT cohort). The median (25th, 75th percentile) eGFR prior to death was 7 (5, 8) mL/min/1.73 m<sup>2</sup>. During the same period, 13 511 individuals started dialysis or received a preemptive kidney transplant (the KRT cohort). There were 7259 individuals in the low eGFR cohort; over the following year, 66% started dialysis, 20% died without dialysis, and 14% were alive without starting dialysis. The clinical approximation is that between 13 and 16% of people with KF die without receiving kidney replacement therapy.</p><p><strong>Limitations: </strong>The data reports lacked certain information to inform the clinical approximation. There was no information on the conversations health professionals had with people about kidney replacement therapy, any decisions made about receiving conservative care, or the circumstances that preceded death without kidney replacement therapy.</p><p><strong>Conclusions: </strong>After reviewing data from the 3 cohorts, we clinically approximate that 1 in 6 people with KF in Ontario, Canada, die without receiving dialysis and should receive conservative kidney management.</p>","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251323961"},"PeriodicalIF":1.6000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11909665/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Kidney Health and Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20543581251323961","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Quantifying the number and proportion of people with kidney failure (KF) who receive conservative kidney management is vital for health care system benchmarking and planning. It is not easy to ascertain this value precisely at the population level, but we can approximate it using information from different data sources to estimate the proportion of patients with advanced kidney disease who die without receiving dialysis or a transplant and should receive conservative kidney management.

Objective: To approximate the proportion of people with KF in Ontario, Canada, who die without receiving kidney replacement therapy.

Design: A review of unpublished provincial renal agency reports of 3 retrospective population-based cohorts combined with clinical interpretation.

Patients: The 3 cohorts of people were: 1. those who died between January 1, 2013 and December 31, 2017, with an estimated glomerular filtration rate (eGFR) <10 mL/min/1.73 m2 and no evidence of receiving kidney replacement therapy; 2. those who initiated outpatient maintenance dialysis or received a preemptive transplant in the same period; and 3. those with a sustained low eGFR ≤ 10 mL/min/1.73 m2 between April 1, 2015 and March 31, 2018, and were followed for 1 year to determine if they started dialysis. In this last cohort, patients whose kidney function improved (evidence of an eGFR > 10 mL/min/1.73 m2) or who received a transplant during follow-up were excluded from the analysis.

Measurements and methods: The 3 cohorts were derived at ICES and used linked health care databases for the province of Ontario, Canada. In 2016, Ontario had a population of about 14 million people. Two nephrologists reviewed the data to provide the clinical approximation.

Results: There were 1891 individuals with KF who died without kidney replacement (the no KRT cohort). The median (25th, 75th percentile) eGFR prior to death was 7 (5, 8) mL/min/1.73 m2. During the same period, 13 511 individuals started dialysis or received a preemptive kidney transplant (the KRT cohort). There were 7259 individuals in the low eGFR cohort; over the following year, 66% started dialysis, 20% died without dialysis, and 14% were alive without starting dialysis. The clinical approximation is that between 13 and 16% of people with KF die without receiving kidney replacement therapy.

Limitations: The data reports lacked certain information to inform the clinical approximation. There was no information on the conversations health professionals had with people about kidney replacement therapy, any decisions made about receiving conservative care, or the circumstances that preceded death without kidney replacement therapy.

Conclusions: After reviewing data from the 3 cohorts, we clinically approximate that 1 in 6 people with KF in Ontario, Canada, die without receiving dialysis and should receive conservative kidney management.

加拿大安大略省肾衰竭患者未接受肾脏替代治疗而死亡的近似比例。
背景:量化接受保守肾管理的肾衰竭(KF)患者的数量和比例对于卫生保健系统的基准和规划至关重要。在人群水平上精确地确定这个值是不容易的,但我们可以使用来自不同数据源的信息来估计晚期肾脏疾病患者不接受透析或移植而死亡并应接受保守肾脏管理的比例。目的:估计加拿大安大略省未接受肾脏替代治疗而死亡的KF患者的比例。设计:回顾未发表的省级肾脏机构的3个回顾性人群队列报告,并结合临床解释。患者:三组患者分别为:1.;2013年1月1日至2017年12月31日期间死亡,估计肾小球滤过率(eGFR) 2且没有接受肾脏替代治疗的证据;2. 在同一时期进行过门诊维持性透析或接受过先期移植的患者;和3。2015年4月1日至2018年3月31日期间持续低eGFR≤10 mL/min/1.73 m2的患者,随访1年以确定是否开始透析。在最后一个队列中,在随访期间肾功能改善(eGFR bb0 10 mL/min/1.73 m2)或接受移植的患者被排除在分析之外。测量和方法:这3个队列来自ICES,并使用了加拿大安大略省的相关卫生保健数据库。2016年,安大略省的人口约为1400万。两位肾病学家回顾了这些数据,以提供临床近似值。结果:1891例KF患者死于无肾置换(无KRT队列)。死亡前eGFR中位数(25、75百分位)为7 (5,8)mL/min/1.73 m2。在同一时期,13 511人开始透析或接受了先发制人的肾移植(KRT队列)。低eGFR队列中有7259人;在接下来的一年里,66%的人开始透析,20%的人在没有透析的情况下死亡,14%的人在没有开始透析的情况下存活。临床估计是13 - 16%的KF患者在未接受肾脏替代治疗的情况下死亡。局限性:数据报告缺乏一定的信息来告知临床近似。没有关于卫生专业人员与患者就肾脏替代疗法进行的对话的信息,没有关于接受保守治疗的任何决定,也没有关于未接受肾脏替代疗法的死亡前情况的信息。结论:在回顾了三个队列的数据后,我们在临床上估计,加拿大安大略省6名KF患者中有1人在没有接受透析的情况下死亡,应该接受保守的肾脏管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.00
自引率
5.90%
发文量
84
审稿时长
12 weeks
期刊介绍: Canadian Journal of Kidney Health and Disease, the official journal of the Canadian Society of Nephrology, is an open access, peer-reviewed online journal that encourages high quality submissions focused on clinical, translational and health services delivery research in the field of chronic kidney disease, dialysis, kidney transplantation and organ donation. Our mandate is to promote and advocate for kidney health as it impacts national and international communities. Basic science, translational studies and clinical studies will be peer reviewed and processed by an Editorial Board comprised of geographically diverse Canadian and international nephrologists, internists and allied health professionals; this Editorial Board is mandated to ensure highest quality publications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信